ATE544851T1 - Verfahren zur deacylierung von zyklischen lipopeptiden - Google Patents

Verfahren zur deacylierung von zyklischen lipopeptiden

Info

Publication number
ATE544851T1
ATE544851T1 AT07114433T AT07114433T ATE544851T1 AT E544851 T1 ATE544851 T1 AT E544851T1 AT 07114433 T AT07114433 T AT 07114433T AT 07114433 T AT07114433 T AT 07114433T AT E544851 T1 ATE544851 T1 AT E544851T1
Authority
AT
Austria
Prior art keywords
hydrogen
hydroxy
deacylation
cyclic
cyclic lipopeptides
Prior art date
Application number
AT07114433T
Other languages
English (en)
Inventor
Satoshi Ueda
Miho Tanaka
Masami Ezaki
Kazutoshi Sakamoto
Seiji Hashimoto
Nobutaka Oohata
Masaru Tsuboi
Michio Yamashita
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of ATE544851T1 publication Critical patent/ATE544851T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT07114433T 1996-03-08 1997-03-06 Verfahren zur deacylierung von zyklischen lipopeptiden ATE544851T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5138696 1996-03-08
JP19420796 1996-07-24

Publications (1)

Publication Number Publication Date
ATE544851T1 true ATE544851T1 (de) 2012-02-15

Family

ID=26391923

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07114433T ATE544851T1 (de) 1996-03-08 1997-03-06 Verfahren zur deacylierung von zyklischen lipopeptiden
AT97905455T ATE439433T1 (de) 1996-03-08 1997-03-06 Prozess für die deacylierung von zyklischen lipopeptiden.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97905455T ATE439433T1 (de) 1996-03-08 1997-03-06 Prozess für die deacylierung von zyklischen lipopeptiden.

Country Status (10)

Country Link
US (3) US6207434B1 (de)
EP (3) EP2172546A1 (de)
JP (1) JP3123078B2 (de)
KR (1) KR100545506B1 (de)
CN (1) CN1161462C (de)
AT (2) ATE544851T1 (de)
CA (1) CA2248348C (de)
DE (1) DE69739532D1 (de)
ES (2) ES2379107T3 (de)
WO (1) WO1997032975A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE544851T1 (de) * 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
WO1997047738A1 (en) * 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
KR20020022758A (ko) * 1999-07-02 2002-03-27 후지야마 아키라 환상 리포펩티드 아실라제를 암호화하는 유전자 및 그 발현
JP2005095001A (ja) * 1999-10-22 2005-04-14 Fujisawa Pharmaceut Co Ltd ヘテロマーペプチドの遺伝子工学的固定化
JP4990456B2 (ja) 1999-12-15 2012-08-01 キュービスト ファーマシューティカルズ， インコーポレイテッド 抗菌剤としてのダプトマイシンアナログ
KR20020063230A (ko) 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서의 신규한 리포펩티드
MXPA02006030A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos como agentes antibacterianos.
JP2005531486A (ja) 2001-08-06 2005-10-20 キュービスト ファーマシューティカルズ， インコーポレイテッド 新規のデプシペプチドおよびこれを調製するためのプロセス
US7045547B2 (en) * 2002-08-20 2006-05-16 University Of Delaware Acyl-CoA dehydrogenase allenic inhibitors
PL2379580T3 (pl) 2008-12-22 2014-05-30 Merck Sharp & Dohme Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
CA2813335A1 (en) 2010-09-30 2012-04-05 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or salts thereof
CN102533551B (zh) * 2010-12-15 2013-10-09 上海天伟生物制药有限公司 一种肽类抗生素的高产菌株及其制备方法和用途
CN102618606B (zh) * 2011-01-30 2014-09-10 浙江海正药业股份有限公司 一种棘白菌素生物转化方法
CN103074403B (zh) * 2011-10-26 2014-07-09 上海医药工业研究院 微生物酶转化棘白菌素b的方法
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627689B (zh) 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN103387975A (zh) 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
IN2015DN01633A (de) * 2012-09-24 2015-07-03 Dsm Sinochem Pharm Nl Bv
KR101425108B1 (ko) * 2012-09-25 2014-07-31 동국제약 주식회사 탈아실화된 환상 리포펩티드의 제조방법
CN106755221A (zh) * 2016-11-28 2017-05-31 无锡福祈制药有限公司 一种米卡芬净母核fr179642的制备方法
CN111909244A (zh) * 2020-08-14 2020-11-10 卓和药业集团有限公司 一种高纯度米卡芬净前体fr901379的制备方法
CN114874919B (zh) * 2022-05-09 2023-06-27 中国科学院青岛生物能源与过程研究所 一株米卡芬净前体fr901379高产菌株及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901469A (fr) 1942-11-27 1945-07-27 Rohm & Haas Ges Mit Beschrankt Procédé pour produire des pellicules, revêtements et analogues ne gonflant pas àpartir de polymérisats simples ou mixtes de composés éthyléniques sous forme de dispersions aqueuses
JPS585189A (ja) * 1981-07-01 1983-01-12 Sanraku Inc 新規なアミドヒドロラ−ゼ
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
GB8925593D0 (en) 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
ATE140728T1 (de) * 1990-06-07 1996-08-15 Lilly Co Eli Lipopeptid deacylase
TW199162B (de) 1991-05-09 1993-02-01 Fujisawa Pharmaceutical Co
GB9506372D0 (en) 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
ATE544851T1 (de) * 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
WO1997047738A1 (en) * 1996-06-13 1997-12-18 Fujisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
KR20020022758A (ko) * 1999-07-02 2002-03-27 후지야마 아키라 환상 리포펩티드 아실라제를 암호화하는 유전자 및 그 발현
JP2005095001A (ja) * 1999-10-22 2005-04-14 Fujisawa Pharmaceut Co Ltd ヘテロマーペプチドの遺伝子工学的固定化

Also Published As

Publication number Publication date
US6207434B1 (en) 2001-03-27
EP2172546A1 (de) 2010-04-07
EP0885957A1 (de) 1998-12-23
US6573084B1 (en) 2003-06-03
EP1854877A3 (de) 2009-05-20
DE69739532D1 (de) 2009-09-24
EP0885957A4 (de) 2004-06-09
KR100545506B1 (ko) 2006-10-04
CN1218507A (zh) 1999-06-02
WO1997032975A1 (en) 1997-09-12
ATE439433T1 (de) 2009-08-15
CA2248348C (en) 2008-06-10
ES2379107T3 (es) 2012-04-20
EP1854877B1 (de) 2012-02-08
EP1854877A2 (de) 2007-11-14
ES2327981T3 (es) 2009-11-05
JP3123078B2 (ja) 2001-01-09
EP0885957B1 (de) 2009-08-12
CN1161462C (zh) 2004-08-11
KR19990087515A (ko) 1999-12-27
US6537789B1 (en) 2003-03-25
CA2248348A1 (en) 1997-09-12

Similar Documents

Publication Publication Date Title
ATE544851T1 (de) Verfahren zur deacylierung von zyklischen lipopeptiden
DE69636147D1 (de) Verfahren zur herstellung von phosphorothioat-oligomeren
ATE217635T1 (de) Zyklische peptide mit antifungischer wirkung und verfahren zu ihrer herstellung
DE69635493D1 (de) Verfahren zur herstellung von l-aminosäuren
ATE321165T1 (de) Funktionelle faserprodukte und verfahren zur herstellung derselben
DE59408901D1 (de) Verfahren zur Herstellung von Polyacetalen
DE69408551D1 (de) Verfahren zur Herstellung von bemaltem Silikon-Elastomer
DE69428403D1 (de) Verfahren zur Herstellung von Azetidinverbindungen und Ausgangsverbindungen dafür
DK0938308T3 (da) Antiparasitiske midler
DE69612086D1 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta-lactonresten
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE59601745D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5-trimethylcyclohexylamin
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
EP0642507A4 (en) Catalytic antibodies against cocaine and methods of using and producing same.
DE69325675D1 (de) Verfahren zur Herstellung von Amid-Verbindungen und Mikroorganismus dafür
DE69313556D1 (de) Verfahren zur Herstellung von zyklischen Depsipeptiden
DE69713040D1 (de) Verfahren zur Herstellung von Cyclopropylacetylen und dessen Derivaten
DE69606128D1 (de) Verfahren zur Zersetzung von Cycloalkylhydroperoxid
DE69606696D1 (de) Selektives verfahren zur deacylierung von acylverbindungen
DE69608384D1 (de) Verfahren zur Herstellung von elastomeren Ethylen-Propylen-Copolymeren
DE59907526D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-cyclohexanon
DE59402263D1 (de) Verfahren zur Herstellung von N-substituierten Pyrrolid-2-onen
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
DE69635422D1 (de) Aminonitril-Zwischenprodukte zur Herstellung von 2-Hydroxyethyliminodiessigsäure
DE69306570D1 (de) Verfahren zur herstellung von ribonukleotid-reduktasehemmern